Logo Université Laval Logo Université Laval
International Chair on Cardiometabolic Risk
My Healthy Waist

Documentation centre

289-300 of 2022 results
Page 25 of 169
Key Publications November 24, 2020

Dietary treatment to lower cholesterol and triglyceride and reduce cardiovascular risk.

Curr Opin Lipidol. 2020;31:206-231

Welty FK
Cardiovascular Disease Lipids/Lipoproteins Nutrition
Key Publications November 24, 2020

When to lower triglycerides?

Curr Opin Lipidol. 2020;31:238-245

Ganda OP
Cardiovascular Disease Lipids/Lipoproteins Prevention
Key Publications November 23, 2020

Can genetic testing help in the management of dyslipidaemias?

Curr Opin Lipidol. 2020;31:187-193

Lazarte J, Hegele RA
Genetics Lipids/Lipoproteins Prevention
Key Publications November 18, 2020

Catch of the day: Icosapent ethyl for reducing cardiovascular risk.

Am J Med. 2020;133:802-804

Dixon DL
Cardiovascular Disease Lipids/Lipoproteins Prevention
Key Publications November 17, 2020

Lower levels of high-density lipoprotein cholesterol are associated with increased cardiovascular events in patients with acute coronary syndrome.

Atherosclerosis. 2020;303:21-28

Nakazawa M, Arashi H, Yamaguchi J, Ogawa H, Hagiwara N
Acute Coronary Syndromes Cardiovascular Disease Lipids/Lipoproteins
Key Publications November 17, 2020

Alterations in plasma triglycerides and ceramides: links with cardiac function in humans with type 2 diabetes.

J Lipid Res. 2020;61:1065-1074

Peterson LR, Jiang X, Chen L, Goldberg AC, Farmer MS, Ory DS, Schaffer JE
Diabetes Inflammation Lipids/Lipoproteins
Key Publications November 11, 2020

Contribution of remnant cholesterol to cardiovascular risk.

J Intern Med. 2020;288:116-127

Langsted A, Madsen CM, Nordestgaard BG
Cardiovascular Disease Lipids/Lipoproteins Prevention
Key Publications November 10, 2020

Profound reductions in first and total cardiovascular events with icosapent ethyl in the REDUCE-IT trial: why these results usher in a new era in dyslipidaemia therapeutics.

Eur Heart J. 2020;41:2304-2312

Boden WE, Bhatt DL, Toth PP, Ray KK, Chapman MJ, Lüscher TF
Cardiovascular Disease Clinical Trials Lipids/Lipoproteins
Key Publications November 10, 2020

Triglyceride-rich particles: new actors in valvular aortic stenosis.

Eur Heart J. 2020;41:2300-2303

Varga A, Hegele RA
Cardiovascular Disease Genetics Lipids/Lipoproteins
Key Publications November 10, 2020

Low-density lipoproteins cause atherosclerotic cardiovascular disease: pathophysiological, genetic, and therapeutic insights: a consensus statement from the European Atherosclerosis Society Consensus Panel.

Eur Heart J. 2020;41:2313-2330

Borén J, Chapman MJ, Krauss RM, Packard CJ, Bentzon JF, Binder CJ, Daemen MJ, Demer LL, Hegele RA, Nicholls SJ, Nordestgaard BG, Watts GF, Bruckert E et al.
Cardiovascular Disease Genetics Lipids/Lipoproteins
Key Publications November 9, 2020

Triglycerides and remnant cholesterol associated with risk of aortic valve stenosis: Mendelian randomization in the Copenhagen General Population Study.

Eur Heart J. 2020;41:2288-2299.

Kaltoft M, Langsted A, Nordestgaard BG
Cardiovascular Disease Genetics Lipids/Lipoproteins
Key Publications November 5, 2020

HDL-apoA-I kinetics in response to 16 wk of exercise training in men with nonalcoholic fatty liver disease.

Am J Physiol Endocrinol Metab. 2020;318:E839-E847

Whyte MB, Shojaee-Moradie F, Sharaf SE, Cuthbertson DJ, Kemp GJ, Barrett M, Jackson NC, Herring RA, Wright J, Thomas EL, Bell J, Umpleby AM
Ectopic Fat Lipids/Lipoproteins Physical Activity/Exercise
of 169